"Urothelial Cancer Clinical Trials Tended to be Small, Identical Between Institutions"
To assess current trends in urothelial cancer research and evaluate opportunities to make best use of successful drug development, Matthew D. Galsky, MD, assistant professor of urology at The Mount Sinai Hospital, and colleagues performed a search of the ClinicalTrials.gov registry for clinical trials designed to explore interventions in muscle-invasive and metastatic urothelial cancer. "Barriers such as insufficient funding and accrual concerns have driven patient resources into small, nonrandomized, single-center trials that are generally not designed, nor intended, to immediately advance current care standards," Galsky and colleagues wrote. Learn more
Mount Sinai Researchers Move Closer to a Cure for Diabetes
Dec 10, 2024 View All Press Releases
Mount Sinai and U.S. Anesthesia Partners Form Alliance to Support New Anesthesia Practice
Dec 05, 2024 View All Press Releases
Mount Sinai Health System Expands Care in Staten Island
Nov 04, 2024 View All Press Releases
Mount Sinai Nurse Hosts Hypertension Series in Harlem
Oct 28, 2024 View All Press Releases
The Tisch Cancer Institute Emphasizes Critical Role of BRCA Testing For All Genders
Oct 14, 2024 View All Press Releases